GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » FDC Ltd (NSE:FDC) » Definitions » Median PS Value

FDC (NSE:FDC) Median PS Value : ₹0.00 (As of Jun. 22, 2024)


View and export this data going back to 1997. Start your Free Trial

What is FDC Median PS Value?

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

Median PS Value is calculated as trailing twelve months (TTM) Revenue per Share times 10-Year median PS Ratio. FDC's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹117.279. FDC's 10-Year median PS Ratio is 0. Therefore, the Median PS Value for today is ₹0.00.

As of today (2024-06-22), FDC's share price is ₹460.70. FDC's Median PS Value is ₹0.00. Therefore, FDC's Price to Median PS Value for today is 0.00.

The historical rank and industry rank for FDC's Median PS Value or its related term are showing as below:

NSE:FDC's Price-to-Median-PS-Value is not ranked *
in the Drug Manufacturers industry.
Industry Median: 0.79
* Ranked among companies with meaningful Price-to-Median-PS-Value only.

FDC Median PS Value Historical Data

The historical data trend for FDC's Median PS Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

FDC Median PS Value Chart

FDC Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Median PS Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

FDC Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Median PS Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of FDC's Median PS Value

For the Drug Manufacturers - Specialty & Generic subindustry, FDC's Price-to-Median-PS-Value, along with its competitors' market caps and Price-to-Median-PS-Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


FDC's Price-to-Median-PS-Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, FDC's Price-to-Median-PS-Value distribution charts can be found below:

* The bar in red indicates where FDC's Price-to-Median-PS-Value falls into.



FDC Median PS Value Calculation

FDC's Median PS Value for today is calculated as

Median PS Value=Revenue per Share (TTM)*10-Year Median PS Ratio
=117.279*0
=0.00

10-Year Median PS Ratio is 0.
FDC's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹117.279.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FDC  (NSE:FDC) Median PS Value Explanation

This valuation method assumes that the stock valuation will revert to its historical (10-Year) mean in terms of PS Ratio. The reason we use PS Ratio instead of PE Ratio or PB Ratio is because PS Ratio is independent of profit margin, and can be applied to a broader range of situations.

It also assumes that over time the profit margin is constant. If a company increases its profit margin to a sustainable level, this value might under-estimate its value. If it has permanent declined profit margins, this may over-estimate the company's value.

FDC's Price to Median PS Value for today is calculated as

Price to Median PS Value=Share Price/Median PS Value
=460.70/0.00
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


FDC Median PS Value Related Terms

Thank you for viewing the detailed overview of FDC's Median PS Value provided by GuruFocus.com. Please click on the following links to see related term pages.


FDC (NSE:FDC) Business Description

Traded in Other Exchanges
Address
C-3 Skyvistas, Near Versova Police Station, D.N. Nagar, Andheri (West), Mumbai, MH, IND, 400053
FDC Ltd is an Indian-based pharmaceutical company with USFDA and UK-MHRA-approved API and formulations manufacturing facilities. It has its presence in numerous therapeutic segments: Anti-infectives, Gastro-Intestinal, Vitamins/Minerals/Nutrients, Ophthalmology/Otologicals, Cardiac, Dermatology, Respiratory, Gynaecology, and Others. The company's brands include Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm. The majority of the revenue is generated domestically.

FDC (NSE:FDC) Headlines

From GuruFocus

Leon Cooperman's Top 5 Holdings

By James Li James Li 06-20-2019

Steve Mandel Starts 3 New Positions in 3rd Quarter

By Sydnee Gatewood Sydnee Gatewood 11-29-2018

Leon Cooperman Buys 15.4 Million Shares of First Data

By David Goodloe David Goodloe 02-19-2016

Leon Cooperman on Surviving Fame and Infamy

By Robert Abbott Robert Abbott 01-31-2018